The Annual General Meeting took place on 21 March 2023
All documents related to the meeting can be found here
To watch a replay of the webcast, please follow the link below.
We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.
With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.
Come join us in making a difference to patients worldwide.
Explore the latest financial developments at Lundbeck.
At Lundbeck, we see patients as people and are committed to support the person behind the disease.
The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.
countries where our products are sold
employees supporting our purpose
year Lundbeck was founded